Johnson & Johnson said on Tuesday the business heads of its three Chinese operations would begin to report to one local chairman next month in an effort to increase sales and centralize corporate oversight. The reorganization comes as pharmaceutical companies are in the spotlight in China after the government began investigating bribery accusations against British drugmaker GlaxoSmithKline. The diversified healthcare company said Jesse Wu, worldwide chairman of its consumer business, will become chairman of J&J China, reporting directly to company Chairman and Chief Executive Alex Gorsky.
Help employers find you! Check out all the jobs and post your resume.
